Long-term survival of treated people living with HIV (PLWH) currently approaches that of the general population. The average age of PLWH is currently in the mid-50s in resource-rich countries and is predicted that over 40% of PLWH will be older than 60 within a decade. Similar trends have been confirmed in all communities of PLWH with access to antiretroviral therapies. However, the positive impact on survival has been challenged by several developments. Ageing PLWH have clinical features similar to the general population about 5-10 years older. In addition to the earlier occurrence of common age-related conditions common geriatric syndromes have also impacted this population prematurely. These are often difficult to evaluate and manag...
Aging with HIV poses unique and complex challenges, including avoidance of neurocognitive disorder. ...
Aging with HIV poses unique and complex challenges, including avoidance of neurocognitive disorder. ...
Cognitive efficiency decreases with age, and advancing age is the leading risk factor for most neuro...
Long-term survival of treated people living with HIV (PLWH) currently approaches that of the general...
Several recent cohort studies have suggested that life expectancy of HIV-infected individuals is cur...
Several recent cohort studies have suggested that life expectancy of HIV-infected individuals is cur...
Modern antiretroviral therapy (ART) has increased longevity of people with HIV and shifted the age d...
The population of people living with HIV (PLWH) is growing older with an estimated 4 million over th...
The population of people living with HIV (PLWH) is growing older with an estimated 4 million over th...
People living with HIV (PLWH) increasingly become older, reflecting the benefit of antiretroviral tr...
The increasing number of aging HIV-infected (HIV+) persons comprises a unique population at risk for...
The prevalence of HIV-infected people aged 50 years or older is increasing rapidly; the proportion w...
Historically, older patients have shown a higher risk of HIV-1-associated dementia (HIVD). The objec...
Historically, older patients have shown a higher risk of HIV-1-associated dementia (HIVD). The objec...
Historically, older patients have shown a higher risk of HIV-1-associated dementia (HIVD). The objec...
Aging with HIV poses unique and complex challenges, including avoidance of neurocognitive disorder. ...
Aging with HIV poses unique and complex challenges, including avoidance of neurocognitive disorder. ...
Cognitive efficiency decreases with age, and advancing age is the leading risk factor for most neuro...
Long-term survival of treated people living with HIV (PLWH) currently approaches that of the general...
Several recent cohort studies have suggested that life expectancy of HIV-infected individuals is cur...
Several recent cohort studies have suggested that life expectancy of HIV-infected individuals is cur...
Modern antiretroviral therapy (ART) has increased longevity of people with HIV and shifted the age d...
The population of people living with HIV (PLWH) is growing older with an estimated 4 million over th...
The population of people living with HIV (PLWH) is growing older with an estimated 4 million over th...
People living with HIV (PLWH) increasingly become older, reflecting the benefit of antiretroviral tr...
The increasing number of aging HIV-infected (HIV+) persons comprises a unique population at risk for...
The prevalence of HIV-infected people aged 50 years or older is increasing rapidly; the proportion w...
Historically, older patients have shown a higher risk of HIV-1-associated dementia (HIVD). The objec...
Historically, older patients have shown a higher risk of HIV-1-associated dementia (HIVD). The objec...
Historically, older patients have shown a higher risk of HIV-1-associated dementia (HIVD). The objec...
Aging with HIV poses unique and complex challenges, including avoidance of neurocognitive disorder. ...
Aging with HIV poses unique and complex challenges, including avoidance of neurocognitive disorder. ...
Cognitive efficiency decreases with age, and advancing age is the leading risk factor for most neuro...